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A  number of early workers  have shown  (1,  2)  that  Bence Jones protein 
injected into animals is rapidly excreted in the urine. That such a  rapid ex- 
cretion of newly synthesized Bence Jones protein also occurs in multiple mye- 
loma patients was first demonstrated by Putnam and Hardy (3, 4) with the 
aid  of  isotopically labeled  amino  acids.  However,  no  quantitative  studies 
regarding the fate of injected Bence Jones protein have been reported either 
with animals or with humans. Such information is necessary to facilitate the 
analysis of the metabolic relationship of Bence Jones protein with the abnormal 
globulins which are synthesized in patients afflicted with multiple myeloma. 
This paper reports on the metabolic fate and the quantitative aspects of the 
excretion of C14--biosynthetically  labeled Bence Jones protein injected intra- 
venously into a single myeloma patient who was synthesizing the protein and 
subsequent  experiments  with  labeled  and  unlabeled  Bence  Jones  proteins 
injected into rabbits. Although the clearance of the protein was not measured, 
this has recently been done by Migita et al. (5), who used la81-conjugated  Bence 
Jones proteins injected into normal human subjects and dogs.  1 The results of 
our work suggest that in spite of the rapid excretion of part of the injected 
protein, a significant portion appears to be metabolized by the recipients. 
EXPER3"MF.NTAL 
Injection of Bence Jones Protein, Measurement of Excretion Rate, and Determination of 
Radioactivity in the Rabbit.--Three a~lnit  female  rabbits were injected  with 4 ml of physiologi- 
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cal saline and  the urine examined for the presence of protein.  It was  thereby established 
that no proteins were excreted under the stress of the experimental conditions. Human Bence 
Jones protein isolated from the urine of two individuals (6-8) was used for further injections. 
Rabbit  1 received a  single injection of 212  mg of unlabeled Bence Jones protein  (Bo.) sus- 
pended in 2  ml of saline.  Rabbit 2  received 2 injections of unlabeled Bence Jones protein 
(He.), one of 108 mg in 5 ml of saline and a  second of 216 nag of the same protein in 5 ml 
saline 4 days later. The third rabbit was injected daily over a period of 9 days; each injection 
was made with 230 nag of C14-1ysine-labeled Bence Jones protein (]3o.) (4388 counts/minute 
for infinite thickness) in 5 ml of saline.  All injections were by the ear vein. 
The urine from all rabbits was collected until the samples no longer showed the presence of 
protein. Total urine volumes were measured, and the amount of protein injected into the rabbit 
and recovered from the urine was estimated by biuret method (9). To avoid interference with 
the biuret reaction by urine pigments, the protein was first precipitated with trichloroacetic 
acid and then dissolved by boiling in pH 8.6 veronal buffer of 0.1 ionic strength. 
For radioactivity determinations, blood samples were drawn from rabbit 3 at  15, 30,  60, 
120, 240,  and  480  minutes after the first intravenous injection of C14-1abeled Bence Jones 
protein. On subsequent days a single blood sample was taken 8 hours after the daily injection. 
After the last injection blood samples were taken for 3 additional days. The rabbit was then 
bled to death by heart puncture and the following organs removed for histological examina- 
tion  and  radioactivity determinations:  spleen,  kidney,  bone  marrow,  appendix,  and  liver. 
The serum from the blood obtained by heart puncture was dialyzed against veronal buffer 
and further fractionated by starch zone electrophoresis. The serum from all blood samples was 
isolated and placed directly on planchets,  as were the various serum fractions obtained by 
starch zone electrophoresis. The isolated organs were ground in a mortar and pestle and also 
placed on planchets. All specimens were counted as dry samples for infinite thickness. 
Injection of Bence Jones Protein into the Human, Collection of Urine, and Determination of 
Radioactivity.--In  a  preceding experiment  (6,  8)  an  adult  male had  been given 450  ye of 
Dr.-glutamie  acid-l-C  14,  and  the excreted protein was found  to have  radioactivity largely 
confined to its glutamic acid. The experiment had been designed to enable follow-up study 
of the fate of the reinjected labeled protein in the donor subject. Hence,  it was continued 
although the patient was now uremic and it was recognized that this might affect the experi- 
mental result.  ~ 
After purification by ammonium sulfate precipitation and  dialysis two  fractions of the 
Bence Jones protein had been obtained, one of which was insoluble in distilled water. A sample 
of 1050 mg of the latter was dissolved in Ringer's solution, titrated to pH 9.5 to achieve solu- 
tion, and readjusted  to pH 7.6.  The solution was centrifuged to remove insoluble material 
and passed through a bacterial filter prior to intravenous injection. An aliquot of 200 ml of 
this solution representing about 0.5 gm protein was injected and the remainder retained for 
reference. 
Except for some nausea with vomiting and a little pyrogenic reaction, the patient suffered 
no ill effects. He reported he felt well the next day, and there were no obvious changes. Fol- 
lowing the injection a total of 29 urine samples were collected over a period of 1 week. The 
samples were dialyzed extensively against distilled water and lyophilized. No serum samples 
were taken because of the patient's anemia, but postmortem specimens of the affected tissues 
were later provided by the pathologist. 
About 200 mg of each of the lyophilized specimens,  a 25 ml aliquot of the original Bence 
2 A similar experiment had been planned for the other patient (Bo.) whose labeled protein 
was used in this study because the protein was more radioactive and had the desired physical 
properties and also because she did not have hyperglobulinemia. However, she returned  to 
the hospital in electrolyte unbalance  and  expired shortly  afterward. PRANZ MEYER  AND  ~FRAITK W. PUTNA~  575 
Jones protein used for injection, and bone marrow taken from the sternum and vertebrae 
of the patient after death were hydrolyzed in 6 N HC1 at 105°C for 24 hours in sealed tubes. 
The hydrolysates were concentrated in a flash evaporator with repeated washings to remove 
the acid. To the final material (about 10 ml in each case) were added 5 ml of 1.25 M acetate 
buffer pH 5.1 and 25 mg of acetone-dried crude glutamic acid decarboxylase  suspended in 10 
ml of distilled water, and the mixture was incubated 2 hours at 37°C. Prior to the addition of 
the decarboxylase the system was flushed with nitrogen to remove preexisting CO2. The re- 
leased CO2 was collected as BaCOs, washed four times with CO2-free  distilled water, four times 
with methanol, and deposited on al,mlnum planchets for measuring radioactivity. 
RESULTS AND DISCUSSION 
Although the radioactive urinary protein excreted by rabbit 3 was pigmented, 
it retained the physicochemical properties of the injected Bence Jones protein 
as well as the capacity to redissolve on boiling. In the analytical ultracentrifuge 
it sedimented as a single peak with an s20.~ of 3.4S, as did  the original protein 
(7).  In the Tiselius electrophoresis apparatus  the excreted protein was more 
heterogeneous,  for it  migrated  as  a  major skewed  peak with  several minor 
components.  However, the mobility of the main component was unchanged. 
The  excreted  protein  was  immunologically similar  to  the  injected  Bence 
Jones protein except for a  small amount of rabbit  serum protein, presumably 
albumin.  8 In  the  Ouchterlony  immunodlffusion test  the  urinary  protein  ex- 
creted by rabbit 3 gave a single precipitin line with antiserum to normal human 
7-globulin, with antiserum to the injected Bence Jones protein  (Bo.), and with 
antiserum to another Bence Jones protein of the same antigenic type (type A). 
In all instances the line fused with the major precipitin line for the injected 
protein,  giving a  reaction of identity.  Although  the  excreted protein  gave a 
faint  precipitin  line  with  anti-rabbit  serum,  the  injected  protein  did  not. 
Similar results were obtained from immunoelectrophoresis in which both the 
injected and excreted proteins gave a precipitin line with anti-normal human 
-g-globulin  but  only  the  excreted  protein  gave  a  reaction  with  anti-rabbit 
Serum, 
The labeled protein which was injected into the patient migrated as a single 
boundary in the Tiselius apparatus. In pH 8.6 veronal buffer it had a mobility 
of -3.4  X  10  -5 cm  2 volt  -1 sec  -1. The twentieth sample of the protein excreted 
after injection had a  major component of the same mobility, but it also con- 
tained several trace components, the fastest of which had the mobility of serum 
albumin,  (Fig.  1).  However, both  samples  were  quite  heterogeneous  in  the 
analytical ultracentrifuge. 
Data presented  in Table I  show  that  only a  fraction of the  Bence Jones 
proteins  injected  into  the  rabbits  was  recovered  in  the  urine.  The  amount 
recovered was characteristic of each protein preparation and reproducible when 
different experimental animals were used. The fraction which was not excreted 
(50 per cent or more) must have been disposed of by some other means. 
s The immunodiffusion  study was performed by Dr. Shunsuke Migita. 576  INJECTED  BENCE  JON'I~S PI~OTEIN 
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It was the above result, together with the experience with the patient (see 
later), that prompted investigation of the metabolic fate of C1~-labeled Bence 
Jones protein. As can be seen from Fig. 2, there was a rapid decline of radio- 
activity in the blood serum of rabbit 3 which can be accounted for in part by 
the rapid excretion of Bence Jones protein in the urine. However,  the extent 
to which the radioactivity declines cannot be explained by excretion alone since 
only 50 per cent of the total injected protein followed this pathway. It must, 
therefore, be assumed  that part of the injected Bence Jones protein was me- 
tabolized or removed from the serum in some other manner. This view is sup- 
ported by the findings given in Fig. 3, which show a steady accumulation of 
radioactivity in the serum during the period of Bence Jones protein injection. 
That indeed some of the Bence Jones protein was metabolized is shown by the 
TABLE I 
Urinary R~y  ~BcnceJon~ ProtdnI~ted~toR~bits 
Bence Jones protein 
He. 
Bo. 
Bo. 
Rabbit No. 
Excreted protein 
First injection 
per cent 
31 
49 
49* 
Second injection 
pot c~ 
29 
* Represents the cumulative  recovery of 1028 mg of the 2070 mg injected. The daily 
excretion after injection  of each 230 mg sample varied from  93 to 147 rag. 
appearance of radioactive material in all the serum proteins isolated (Table 
II). This conclnsion is consistent with an observation that the urinary urea also 
contained measurable  C  14.  Furthermore, the  albumin had a  higher specific 
activity than the starch zone fraction which would have contained material 
with the mobility of the injected Bence Jones protein. 
Among  the various organs  isolated from the rabbit,  the kidney had the 
highest specific activity. Histological examln~tion of this organ did not reveal 
any pathological changes and seemed to exclude the possibility that the Bence 
Jones protein was precipitated in the tubules.  Since the kidney has an active 
system for metabolizing  proteins, it seems unlikely  that the Bence Jones protein 
was stored intracellularly in this organ in its original form. 
Very little radioactivity was found in the urinary protein of the myeloma 
patient during the 1 week period following injection of his own labeled protein, 
nor could any radioactivity be detected in the isolated bone marrow. Although 
the latter might have been predicted, his failure to excrete a substantial frac- 
tion of the labeled protein within the first 8 hours after injection was surprising. 578  INJECTED BENCE  JOISTES  PROTEIN 
Several months earlier after a single injection of glutamic acid-C  14, the same 
patient had excreted  more than half the labeled Bence Jones protein in the 
first 10 hours that he did over the 60 hour period of study. Yet, in the present 
experiment the radioactivity of the BaCO8 from the Bence Jones protein of the 
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FIo.  2.  Decline of serum radioactivity in a  rabbit during an 8 hour period following the 
injection of labeled Bence Jones protein. 
first eight specimens of urine was only 50 per cent above background; the thick 
sample count was only 23 to 33 c. P. ~. compared to 2245 for the injected sample. 
This result could not be explained by simple dilution with newly synthesized 
unlabeled protein, for the patient would only have excreted  about five times 
the injected amount in a  12 hour period. 
Assuming that the injected protein had not been altered during the initial 
isolation from the patient's urine,  the loss of radioactivity could be explained FRANz  MEYER  AND  FRANK  W.  PUTNAM  579 
by the existence of a large body pool of Bence Jones protein, which could mix 
with and dilute the injected protein. This seems unlikely in view of the pre- 
ceding experiment with this patient  (6, 8) and other isotopic studies (3, 4, 7, 
10) which have shown Bence Jones protein to be synthesized and excreted very 
rapidly. In this case when the patient was uremic and had a low urea clearance, 
a more plausible explanation is that much of the protein was deposited in the 
tissues and subsequently metabolized. Earlier study (6, 8) had shown that this 
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Fzo.  3.  Serum radioactivity in a  rabbit over a  12 day period with repeated injections of 
labeled Bence  Jones  protein. Arrows  indicate the time of injection. 
Bence Jones protein was variable in its physical properties. In fact, the injected 
sample  was  the fraction  which  was  insoluble in  distilled  water and  poorly 
soluble in saline.  It may have been denatured during the isolation and in the 
process of dissolving  in Ringer's solution by the titration to pH 9.5. Thus, the 
poor solubility may have  rendered  it  more susceptible to phagocytosis.*  It 
should be borne in mind that only 30 per cent of this Bence Jones protein was 
excreted when injected into rabbits. 
In view of the extensive metabolism of a more soluble Bence Jones protein 
by these animals,  it seems likely that the same process was occurring  in the 
human.  In contrast to the rabbit, a myeloma patient requires a large  supply 
of amino acids for the synthesis of excessive quantities of abnormal  proteins. 
4 A  further portion of the reexcreted labeled protein may have been lost during the re- 
isolation which also involved dialysis against distilled water. 580  INJECTED BENCE JONES PROTEIN 
These patients  are usually in  a  wasting condition and  in negative nitrogen 
balance. This subject had an average daily protein intake of only 32 gm before 
the experiment; yet he was excreting about 5 gm of Bence Jones protein per 
day. Furthermore, according to the isotope balance data of the earlier experi- 
ment, he was  synthesizing much more myeloma globulin  than Bence Jones 
protein  (8).  It  is probable he had  a  particularly active enzyme system for 
metabolizing proteins, which could account in part for the virtual absence of 
radioactivity in the urinary protein. 
Since rabbits, dogs (5), and normal humans (5) rapidly excrete a substantial 
fraction of injected Bence Jones protein,  s it would be valuable to repeat this 
experiment with other myeloma patients who excrete a more soluble and homo- 
geneous protein and who are not exhibiting signs of renal failure,  s 
TABLE H 
Radioactivity of Di.fferent Organs and Serum Fractions, 3 Days after the Last Injection  of 
Labeled Bence Jones Protein (Bo.) into Rabbit 3 
Counts/mln. for  Serum fraction  Counts/min. for  Organ  infinite thickness  infinite thickness 
Kidney 
Spleen 
Liver 
Appendix 
Bone marrow 
90.1 
11.9 
12.0 
12.0 
9.8 
Albumin 
~-Globulin 
:l-Globulin 
Fraction  having  mobility  of 
Bence Jones protein 
~-Globulin 
40.9 
19.1 
18.0 
32.2 
17.0 
SUMMARy 
Bence Jones protein injected into rabbits was excreted rapidly into the urine. 
The  excreted  protein  retained  the  physicochemical  and  immunochemical 
properties of the injected Bence Jones protein. In spite of the rapid excretion, 
a  significant portion of the  injected Bence Jones protein was  found to  be 
metabolized. After reinjection of radioactive Bence Jones protein into the donor 
patient, only a little radioactivity was recovered in the urinary protein. The 
implications of these results are discussed. 
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